Transbiomed

Recent Finacing

Equity

Recent Raise

Undisclosed

Transbiomed develops a urine-based diagnostic device for early, non-invasive detection of prostate cancer and conducts clinical validation studies in Spanish hospitals as a VHIR spin-off.